Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Korfel A, Martus P, Nowrousian MR, Hossfeld DK, Kirchen H, Brücher J, Stelljes M, Birkmann J, Peschel C, Pasold R, Fischer L, Jahnke K, Thiel E; German primary central nervous system lymphoma Study Group (G-PCNSL-SG).
Korfel A, et al. Among authors: fischer l.
Br J Haematol. 2005 Jan;128(2):177-83. doi: 10.1111/j.1365-2141.2004.05284.x.
Br J Haematol. 2005.
PMID: 15638851
Free article.
Clinical Trial.